Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins

Ching-Pin Chang, Yakop Jacobs, Takuro Nakamura, Nancy A. Jenkins, Neal G. Copeland, Michael L. Cleary

Research output: Contribution to journalArticle

195 Citations (Scopus)

Abstract

The Pbx1 and Meis1 proto-oncogenes code for divergent homeodomain proteins that are targets for oncogenic mutations in human and murine leukemias, respectively, and implicated by genetic analyses to functionally collaborate with Hbx proteins during embryonic development and/or oncogenesis. Although Pbx proteins have been shown to dimerize with Hbx proteins and modulate their DNA binding properties in vitro, the biochemical compositions of endogenous Pbx-containing complexes have not been determined. In the present study, we demonstrate that Pbx and Meis proteins form abundant complexes that comprise a major Pbx-containing DNA binding activity in nuclear extracts of cultured cells and mouse embryos. Pbx1 and Meis1 dimerize in solution and cooperatively bind bipartite DNA sequences consisting of directly adjacent Pbx and Meis half sites. Pbx1-Meis1 heterodimers display distinctive DNA binding specificities and cross-bind to a subset of Pbx-Hox sites, including those previously implicated as response elements for the execution of Pbx-dependent Hbx programs in vivo. Chimeric oncoprotein E2a- Pbx1 is unable to bind DNA with Meis1, due to the deletion of amino-terminal Pbx1 sequences following fusion with E2a. We conclude that Meis proteins are preferred in vivo DNA binding partners for wild-type Pbx1, a relationship that is circumvented by its oncogenic counterpart E2a-Pbx1.

Original languageEnglish (US)
Pages (from-to)5679-5687
Number of pages9
JournalMolecular and Cellular Biology
Volume17
Issue number10
StatePublished - Oct 1997
Externally publishedYes

Fingerprint

DNA
Proteins
Homeodomain Proteins
Proto-Oncogenes
Oncogene Proteins
Response Elements
Embryonic Development
Cultured Cells
Carcinogenesis
Leukemia
Embryonic Structures
Mutation
In Vitro Techniques

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Chang, C-P., Jacobs, Y., Nakamura, T., Jenkins, N. A., Copeland, N. G., & Cleary, M. L. (1997). Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. Molecular and Cellular Biology, 17(10), 5679-5687.

Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. / Chang, Ching-Pin; Jacobs, Yakop; Nakamura, Takuro; Jenkins, Nancy A.; Copeland, Neal G.; Cleary, Michael L.

In: Molecular and Cellular Biology, Vol. 17, No. 10, 10.1997, p. 5679-5687.

Research output: Contribution to journalArticle

Chang, C-P, Jacobs, Y, Nakamura, T, Jenkins, NA, Copeland, NG & Cleary, ML 1997, 'Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins', Molecular and Cellular Biology, vol. 17, no. 10, pp. 5679-5687.
Chang C-P, Jacobs Y, Nakamura T, Jenkins NA, Copeland NG, Cleary ML. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. Molecular and Cellular Biology. 1997 Oct;17(10):5679-5687.
Chang, Ching-Pin ; Jacobs, Yakop ; Nakamura, Takuro ; Jenkins, Nancy A. ; Copeland, Neal G. ; Cleary, Michael L. / Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. In: Molecular and Cellular Biology. 1997 ; Vol. 17, No. 10. pp. 5679-5687.
@article{1b4878ae1f7143a5989026ec5b3f954d,
title = "Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins",
abstract = "The Pbx1 and Meis1 proto-oncogenes code for divergent homeodomain proteins that are targets for oncogenic mutations in human and murine leukemias, respectively, and implicated by genetic analyses to functionally collaborate with Hbx proteins during embryonic development and/or oncogenesis. Although Pbx proteins have been shown to dimerize with Hbx proteins and modulate their DNA binding properties in vitro, the biochemical compositions of endogenous Pbx-containing complexes have not been determined. In the present study, we demonstrate that Pbx and Meis proteins form abundant complexes that comprise a major Pbx-containing DNA binding activity in nuclear extracts of cultured cells and mouse embryos. Pbx1 and Meis1 dimerize in solution and cooperatively bind bipartite DNA sequences consisting of directly adjacent Pbx and Meis half sites. Pbx1-Meis1 heterodimers display distinctive DNA binding specificities and cross-bind to a subset of Pbx-Hox sites, including those previously implicated as response elements for the execution of Pbx-dependent Hbx programs in vivo. Chimeric oncoprotein E2a- Pbx1 is unable to bind DNA with Meis1, due to the deletion of amino-terminal Pbx1 sequences following fusion with E2a. We conclude that Meis proteins are preferred in vivo DNA binding partners for wild-type Pbx1, a relationship that is circumvented by its oncogenic counterpart E2a-Pbx1.",
author = "Ching-Pin Chang and Yakop Jacobs and Takuro Nakamura and Jenkins, {Nancy A.} and Copeland, {Neal G.} and Cleary, {Michael L.}",
year = "1997",
month = "10",
language = "English (US)",
volume = "17",
pages = "5679--5687",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins

AU - Chang, Ching-Pin

AU - Jacobs, Yakop

AU - Nakamura, Takuro

AU - Jenkins, Nancy A.

AU - Copeland, Neal G.

AU - Cleary, Michael L.

PY - 1997/10

Y1 - 1997/10

N2 - The Pbx1 and Meis1 proto-oncogenes code for divergent homeodomain proteins that are targets for oncogenic mutations in human and murine leukemias, respectively, and implicated by genetic analyses to functionally collaborate with Hbx proteins during embryonic development and/or oncogenesis. Although Pbx proteins have been shown to dimerize with Hbx proteins and modulate their DNA binding properties in vitro, the biochemical compositions of endogenous Pbx-containing complexes have not been determined. In the present study, we demonstrate that Pbx and Meis proteins form abundant complexes that comprise a major Pbx-containing DNA binding activity in nuclear extracts of cultured cells and mouse embryos. Pbx1 and Meis1 dimerize in solution and cooperatively bind bipartite DNA sequences consisting of directly adjacent Pbx and Meis half sites. Pbx1-Meis1 heterodimers display distinctive DNA binding specificities and cross-bind to a subset of Pbx-Hox sites, including those previously implicated as response elements for the execution of Pbx-dependent Hbx programs in vivo. Chimeric oncoprotein E2a- Pbx1 is unable to bind DNA with Meis1, due to the deletion of amino-terminal Pbx1 sequences following fusion with E2a. We conclude that Meis proteins are preferred in vivo DNA binding partners for wild-type Pbx1, a relationship that is circumvented by its oncogenic counterpart E2a-Pbx1.

AB - The Pbx1 and Meis1 proto-oncogenes code for divergent homeodomain proteins that are targets for oncogenic mutations in human and murine leukemias, respectively, and implicated by genetic analyses to functionally collaborate with Hbx proteins during embryonic development and/or oncogenesis. Although Pbx proteins have been shown to dimerize with Hbx proteins and modulate their DNA binding properties in vitro, the biochemical compositions of endogenous Pbx-containing complexes have not been determined. In the present study, we demonstrate that Pbx and Meis proteins form abundant complexes that comprise a major Pbx-containing DNA binding activity in nuclear extracts of cultured cells and mouse embryos. Pbx1 and Meis1 dimerize in solution and cooperatively bind bipartite DNA sequences consisting of directly adjacent Pbx and Meis half sites. Pbx1-Meis1 heterodimers display distinctive DNA binding specificities and cross-bind to a subset of Pbx-Hox sites, including those previously implicated as response elements for the execution of Pbx-dependent Hbx programs in vivo. Chimeric oncoprotein E2a- Pbx1 is unable to bind DNA with Meis1, due to the deletion of amino-terminal Pbx1 sequences following fusion with E2a. We conclude that Meis proteins are preferred in vivo DNA binding partners for wild-type Pbx1, a relationship that is circumvented by its oncogenic counterpart E2a-Pbx1.

UR - http://www.scopus.com/inward/record.url?scp=0030813558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030813558&partnerID=8YFLogxK

M3 - Article

C2 - 9315626

AN - SCOPUS:0030813558

VL - 17

SP - 5679

EP - 5687

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 10

ER -